In India, people familiar with the development said the company is in discussions with Dr Reddy’s Laboratories, Cipla, Jubilant Lifesciences, and Strides Pharmaceuticals for granting them voluntary licences for manufacturing the drug.from Industry-Economic Times
Read The Rest:economictimes...
